CARMELL THERAPEUTICS
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repai... red tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).
CARMELL THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Device Therapeutics
Founded:
2007-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.carmellrx.com
Total Employee:
1+
Status:
Active
Contact:
4122088033
Email Addresses:
[email protected]
Total Funding:
9.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Works
Innovation Works investment in Seed Round - Carmell Therapeutics
Jay Yue
Jay Yue investment in Convertible Note - Carmell Therapeutics
Maine Angels
Maine Angels investment in Series B - Carmell Therapeutics
Keiretsu Forum
Keiretsu Forum investment in Series B - Carmell Therapeutics
Harbor Light Capital Partners
Harbor Light Capital Partners investment in Series B - Carmell Therapeutics
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - Carmell Therapeutics
Newlin Investment Company
Newlin Investment Company investment in Series B - Carmell Therapeutics
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - Carmell Therapeutics
Lehigh Valley Angel Investors
Lehigh Valley Angel Investors investment in Angel Round - Carmell Therapeutics
Innovation Works
Innovation Works investment in Debt Financing - Carmell Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-11 | Carmell Therapeutics Announces the Appointment of Sebastian “Sebby” Borriello to Chief Business Officer |
Official Site Inspections
http://www.carmellrx.com
- Host name: fwdlb.pairnic.net
- IP address: 216.92.3.120
- Location: Pittsburgh United States
- Latitude: 40.4236
- Longitude: -79.9825
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15203
More informations about "Carmell Therapeutics"
Carmell Therapeutics - Crunchbase Company Profile & Funding
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the …See details»
Carmell Therapeutics - Overview, News & Similar companies
Explore Complete Organization Structure. Is Carmell Therapeutics your ideal customer? Let us give you the heads up on whether it's a good time to reach out. ... Carmell Therapeutics …See details»
Alpha Healthcare Acquisition Corp. III Announces …
Jan 5, 2023 Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft ...See details»
Carmell Therapeutics Company Profile | Management and
[email protected]: Carmell Therapeutics Top Competitors. Company Employees Revenue Top technologies; Isofol Medical. n/a: $2.1 M: Topas Therapeutics. n/a: $5.9 M: OZ …See details»
Alpha Healthcare Acquisition Corp. III Announces Successful …
Jul 14, 2023 For more information, visit www.carmellrx.com. Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
Carmell Regen Med Corp. - Drug pipelines, Patents, Clinical trials ...
Explore Carmell Regen Med Corp. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 11 news, and 2 literature, Technology Platform ...See details»
Carmell Corporation Announces Completion of Post …
PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with ...See details»
EX-99.1 - SEC.gov
Sep 5, 2023 Carmell’s R&D pipeline includes cosmetic and dental products under development. For more information, visit www.carmellrx.com . Forward-Looking Statements. This press …See details»
Cantilever Investors | Carmell Therapeutics
Biotechnology. Carmell is a biotechnology company focused on the development and commercialization of regenerative medicine technologies. Founded as a spin-out of Carnegie …See details»
Carmell Therapeutics - VentureRadar
Website: http://www.carmellrx.com. Offers proprietary Plasma-based Bioactive Materials technology for improving patient outcomes and reducing healthcare costs ...See details»
Why Pittsburgh biotech company Carmell Therapeutics is going …
Sep 12, 2022 Why is Carmell Therapeutics, poised to become the newest public company in the Pittsburgh region, taking that big step? CEO Randy Hubbell said it's the right move for the …See details»
Carmell Corporation Announces Completion of Post-Merger …
Sep 5, 2023 For more information, visit www.carmellrx.com Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
Carmell Therapeutics Announces Merger with Axolotl Biologix, a ...
Jul 27, 2023 For more information, visit www.carmellrx.com. Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
Carmell Therapeutics Announces the Appointment of Sebastian …
May 11, 2022 Randy Hubbell [email protected] (412) 894-1875 Release Summary Sebastian "Sebby" Borriello joins Carmell Therapeutics bringing 30+ years of pharmaceutical, …See details»
Carmell Therapeutics Email Format | carmellrx.com Emails
The most common Carmell Therapeutics email format is [first_initial][last] (ex. [email protected]), which is being used by 92.0% of Carmell Therapeutics work email …See details»
Carmell Cosmetics
This three piece Face and Neck collection brings the full Carmell Secretome™ line to your skincare routine. This kit contains: Regenerative Elixir: The Carmell Secretome™ flagship, our …See details»
Carmell Therapeutics Receives IND Clearance for CT-101, Bone …
Jan 7, 2020 For Media Inquires: Randy Hubbell [email protected] (412) 894-1875 Contacts. For Media Inquires: Randy Hubbell [email protected] (412) 894-1875 Site …See details»
Carmell Corporation Announces Completion of Post-Merger
Sep 5, 2023 For more information, visit www.carmellrx.com Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
FDA grants Carmell Therapeutics Expedited Review for CT-101, …
Apr 27, 2020 For Media Inquires: Randy Hubbell [email protected] (412) 894-1875 Site Navigation. Home. Home; Submit a Press Release; Services; News. All News; News with …See details»